Molecular evidence of plasmodium vivax mono and mixed malaria parasite infections in duffy-negative native cameroonians

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Mbenda, Huguette Gaelle Ngassa ^a   Das, Aparup ^a  

^a NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCUMSPOROZOITE PROTEIN; DNA; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; RIBOSOME RNA;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BLACK PERSON; BLOOD GROUP DUFFY SYSTEM; BLOOD SAMPLING; CAMEROON; CAMEROONIAN; CSP GENE; DNA SEQUENCE; ERYTHROCYTE; FEMALE; GENE MUTATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MDR1 GENE; MIDDLE AGED; MIXED INFECTION; MOLECULAR DIAGNOSIS; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE IDENTIFICATION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; RNA GENE; SEQUENCE ALIGNMENT; VERY ELDERLY; YOUNG ADULT;

EID: 84905400914     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103262     Document Type: Article

References (40)

1. World Health Organization (2013) World malaria report: 2013.
2. Singh B, Kim SL, Matusop A, Radhakrishnan A, Shamsul SS, et al. (2004) A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet 363: 1017-1024. (Pubitemid 38410774)
3. Tyagi RK, Das MK, Singh SS, Sharma YD (2013) Discordance in drug resistance-associated mutation patterns in marker genes of Plasmodium falciparum and Plasmodium knowlesi during coinfections. J Antimicrob Chemother 68: 1081-1088.
4. Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, et al. (1993) High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol 61: 315-320.
5. Johnston SP, Pieniazek NJ, Xayavong MV, Slemenda SB, Wilkins PP, et al. (2006) PCR as a confirmatory technique for laboratory diagnosis of malaria. J Clin Microbiol 44: 1087-1089.
6. Gupta B, Gupta P, Sharma A, Singh V, Dash AP, et al. (2010) High proportion of mixed-species Plasmodium infections in India revealed by PCR diagnostic assay. Trop Med Inter Health 15: 819-824.
7. Ryan JR, Stoute JA, Amon J, Dunton RF, Mtalib R, et al. (2006) Evidence for transmission of Plasmodium vivax among a Duffy antigen negative population in western Kenya. Am J Trop Med Hyg 75: 575-581. (Pubitemid 46941258)
8. Culleton R, Ndounga M, Zeyrek FY, Coban C, Casimiro PN, et al. (2009) Evidence for the transmission of Plasmodium vivax in the Republic of the Congo, West Central Africa. J Infect Dis 200: 1565-1569.
9. Ménard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, et al. (2010) Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci USA 107: 5967-5971.
10. Dhorda M, Nyehangane D, Rénia L, Piola P, Guerin PJ, et al. (2011) Transmission of Plasmodium vivax in south-western Uganda: report of three cases in pregnant women. PLoS One 6: 19801.
11. Mendes C, Dias F, Figueiredo J, Mora VG, Cano J, et al. (2011) Duffy negative antigen is no longer a barrier to Plasmodium vivax-molecular evidences from the African West Coast (Angola and Equatorial Guinea). Plos Negl Trop Dis 5: e1192.
12. Wurtz N, Mint LK, Bogreau H, Pradines B, Rogier C, et al. (2011) Vivax malaria in Mauritania includes infection of a Duffy negative individual. Malar J 10: 336.
13. Woldearegai TG, Kremsner PG, Kun JF, Mordmuller B (2013) Plasmodium vivax malaria in Duffy-negative individuals from Ethiopia. Trans R Soc Trop Med Hyg 107: 328-331.
14. Miller LH, Mason SJ, Clyde DF, McGinniss MH (1976) The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. New Engl J Med 295: 302-304.
15. Mendis K, Sina BJ, Marchesini P, Carter R (2001) The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64: 97-106. (Pubitemid 32552576)
16. Gething PW, Elyazar IRF, Moyes CL, Smith DL, Battle KE, et al. (2012) A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis 6: e1814.
17. Hamblin MT, Di-Rienzo A (2000) Detection of the signature of natural selection in humans: evidence from the Duffy blood group locus. Am J Hum Genet 66: 1669-1679. (Pubitemid 30463085)
18. Liu W, Li Y, Shaw KS, Learn GH, Plenderleith LJ, et al. (2014) African origin of the malaria parasite Plasmodium vivax . Nat Commun 5: 3346, DOI: 10.1038.
19. Culleton RL, Mita T, Ndounga M, Unger H, Cravo PV, et al. (2008) Failure to detect Plasmodium vivax in west and central africa by PCR species typing. Malar J 7: 174.
20. World Health Organization (2012) World malaria report: 2012.
21. Ngassa MHG, Awasthi G, Singh PK, Gouado I, Das A (2014) Does malaria epidemiology project Cameroon as "Africa in Miniature"? J Bios 39: 1-11.
22. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, et al. (2010) The international limits and population at risk of Plasmodium vivax transmission in 2009. Plos Negl Trop Dis 4: e774.
23. Fru-Cho J, Bumah VV, Safeukui I, Nkuo-Akenji T, Titanji PKV, et al. (2014) Molecular typing reveals substantial Plasmodium vivax infection in asymptomatic adults in a rural area of Cameroon. Malar J 13: 170.
24. Imwong M, Pukrittayakamee S, Grüner AC, Rénia L, Letourneur F, et al. (2005) Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp-1. Malar J 4: 20.
25. Qari SH, Shi YP, Goldman IF, Udhayakumar V, Alpers MP, et al. (1993a) Identification of Plasmodium vivax-like human malaria parasite. Lancet 341: 780-783. (Pubitemid 23096285)
26. Lekweiry KM, Ali Ould Mohamed Salem B, Gaillard T, Wurtz N, Bogreau H, et al. (2012) Molecular surveillance of drug-resistant Plasmodium vivax using pvdhfr, pvdhps and pvmdr1 markers in Nouakchott, Mauritania. J Antimicrob Chemother 67: 367-374.
27. Vathsala PG, Pramanik A, Dhanasekaran S, Devi CU, Pillai CR, et al. (2004) Widespread occurrence of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) gene haplotype SVMNT in P. falciparum malaria in India. Am. J. Trop. Med. Hyg. 70, 256-259. (Pubitemid 38366528)
28. Basco LK, Ringwald P (2002) Molecular epidemiology of malaria in Cameroon. X. Evaluation of PFMDR1 mutations as genetic markers for resistance to amino alcohols and artemisinin derivatives. Am J Trop Med Hyg 66: 667-671. (Pubitemid 35005825)
29. Chittoria A, Mohanty S, Jaiswal YK, Das A (2012) Natural selection mediated association of the Duffy (FY) gene polymorphisms with Plasmodium vivax malaria in India. PLoS ONE 7: e45219.
30. Hamblin MT, Thompson EE, Di Rienzo A (2002) Complex signatures of natural selection at the Duffy blood group locus. Am J Hum Genet 70: 369-383. (Pubitemid 34112292)
31. Tournamille C, Colin Y, Cartron JP, Le Van Kim C (1995) Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 10: 224-228.
32. de Souza-Neiras WC, de Melo LM, Machado RL (2007) The genetic diversity of Plasmodium vivax: a review. Mem Inst Oswaldo Cruz 102: 245-254.
33. Kim JR, Imwong M, Nandy A, Chotivanich K, Nontprasert A, et al. (2006) Genetic diversity of Plasmodium vivax in Kolkata, India. Malaria J 5: 71.
34. Dhangadamajhi G, Rout BK, Kar SK, Ranjit MR (2010) Genetic diversity of Plasmodium vivax in a hyperendemic area predominated by Plasmodium falciparum; a preliminary study. Trop Biomed 27: 578-584.
35. Taye A, Hadis M, Adugna N, Tilahun D, Wirtz RA (2006) Biting behavior and Plasmodium infection rates of Anopheles arabiensis from Sille, Ethiopia. Acta Trop 97: 50-54. (Pubitemid 41758516)
36. Gupta B, Dash AP, Shrivastava N, Das A (2010) Single nucleotide polymorphisms, putatively neutral DNA markers and population genetic parameters in Indian Plasmodium vivax isolates. Parasitol 137: 1721-1730.
37. Gupta B, Srivastava N, Das A (2012) Inferring the evolutionary history of Indian Plasmodium vivax from population genetic analyses of multilocus nuclear DNA fragments. Mol Ecol 21: 1597-1616.
38. Ngassa MHG, Das A (2014) Occurrence of multiple chloroquine-resistant Pfcrt haplotypes and emergence of the S(agt)VMNT type in Cameroonian Plasmodium falciparum. J Antimicrob Chemother 69: 400-403.
39. World Health Organization (2006) Guidelines for the treatment of malaria. Geneva, Switzerland: WHO.
40. National Malaria Control Programme (2007) National guidelines for the treatment of malaria. Yaounde, Cameroon: National Malaria Control Programme.